Highlights Repligen Corporation

Equities

RGEN

US7599161095

Real-time Estimate Cboe BZX Other stock markets 03:23:26 2024-05-02 pm EDT			5-day change	1st Jan Change
164.6 ^USD	+3.92%		-0.59%	-8.40%

05:34pm	UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating	MT
May. 01	Repligen's Q1 Adjusted Earnings, Revenue Fall	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Repligen's Q1 Adjusted Earnings, Revenue Fall	May. 01	MT
(RGEN) REPLIGEN CORPORATION Sees Fiscal Year 2024 EPS Range $1.42 - $1.49	May. 01	MT
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Q1 Revenue $151.3M, vs. Street Est of $150.1M	May. 01	MT
Earnings Flash (RGEN) REPLIGEN CORPORATION Posts Adjusted Q1 EPS $0.28, vs. Street Est of $0.30	May. 01	MT
Repligen Corporation Provides Earnings Guidance for the Fiscal Year 2024	May. 01	CI
Repligen Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 01	CI
North American Morning Briefing : Traders Wait for -2-	May. 01	DJ
Repligen Q4 Adjusted Earnings, Revenue Decline; Issues 2024 Guidance; Shares Fall Premarket	Feb. 21	MT
Sartorius falls - outlook from Repligen disappointed	Feb. 21	DP
(RGEN) REPLIGEN CORPORATION Expects Fiscal Year 2024 EPS Range $1.42 - $1.49	Feb. 21	MT
Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 Revenue $155.7M, vs. Street Est of $156.3M	Feb. 21	MT
Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q4 EPS $0.33, vs. Street Est of $0.34	Feb. 21	MT
Repligen Corporation Provides Earnings Guidance for the Year 2024	Feb. 21	CI
Repligen Corporation Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 21	CI
Repligen Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 21	CI
Repligen to Seek Acquisitions	Dec. 07	CI
Repligen Corporation Launches TangenX®? SC as First-To-Market Holder-Free Self-Contained TFF Device	Nov. 02	CI
Repligen Q3 Adjusted Earnings, Revenue Fall; 2023 Adjusted EPS Outlook Lowered, Revenue Guidance Revised	23-10-31	MT
(RGEN) REPLIGEN CORPORATION Sees Fiscal Year 2023 EPS Range $1.70 - $1.76	23-10-31	MT
Earnings Flash (RGEN) REPLIGEN CORPORATION Reports Q3 Revenue $141.2M, vs. Street Est of $140.6M	23-10-31	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Repligen Corporation

Equities

RGEN

US7599161095

Highlights

Filters